Roche Offers $5.7 Billion for Gene Company Illumina
Swiss drug giant Roche made a hostile offer for Illumina that values the DNA sequencing company at .7 billion, underscoring growing interest in the competitive field of gene sequencing.
Swiss drug giant Roche made a hostile offer for Illumina that values the DNA sequencing company at .7 billion, underscoring growing interest in the competitive field of gene sequencing.